Bub1 is a component of the mitotic spindle checkpoint apparatus. Abnormality of this apparatus is known to cause multinuclei formation, a hallmark of chromosomal instability (CIN). A549, aneuploid cell line, aberrantly passed through the mitotic phase and became multinuclei morphology in the presence of nocodazole. Time-lapse videomicroscopy showed unreported bizarre morphology, which we named 'mitotic lobulation' in A549 cells just before the exit from mitosis and multinuclei formation. External expression of wild-type Bub1-EGFP clearly suppressed the multinuclei formation by retaining A549 cells at the mitotic phase during 48 h of time-lapse observation. This suppressive effect on mitotic aberrancy should not be mere restoration of normal Bub1 function, because A549 cells express proper amount of Bub1, which distributed cytoplasm during interphase and concentrated at kinetochore in metaphase. Furthermore, external expression of wild-type Bub1-EGFP suppressed multinuclei formation induced by Tax both in A549 and HeLa cells. Tax is known to induce mitotic abnormality by binding and inactivating Mad1. These observations, therefore, suggest functional redundancy between Bub1 and other mitotic checkpoint protein(s) and a possibility of correction of mitotic aberrancy by external Bub1 expression.
Introduction
Genomic instability is a common feature of human cancer and is thought to enhance multistep tumorigenesis. At least two categories of instability have been described: chromosomal instability (CIN) and microsatellite instability (MIN) . CIN leads to an abnormal chromosomal number (aneuploidy). Most solid tumors and hematopoietic malignancies often show abnormal chromosomal numbers. Normal distribution of chromosomes during mitosis is under surveillance of the spindle assembly checkpoint proteins encoded by the BUB and MAD gene groups and MPS1 (Hoyt et al., 1991; Li and Murray, 1991; Weiss and Winey, 1996) . The checkpoint delays the metaphase to anaphase transition until all pairs of sister chromatids are properly attached to spindle microtubules (Jallepalli and Lengauer, 2001; Nigg, 2001) . Functional inactivation of these proteins can cause abnormal mitosis, leading to chromosomal mis-segregation, apoptosis, aneuploidy, or multinucleated cells. Nocodazole, a representative microtubule-destabilizing agent, prevents assembly of microtubules by binding primarily to the ab-tubulin dimmer. Nocodazole treatment has been used to enhance aneuploidy and multinuclei formation and thereby to detect abnormalities in some checkpoint genes (Majone et al., 1993; Taylor and Mckeon, 1997; Jin et al., 1998; Chan et al., 1999; Bahar et al., 2002; Chen and Horwitz, 2002) .
HTLV-1 is the etiologic agent for adult T-cell leukemia/lymphoma (ATLL). The ATLL shows complex karyotypes in number and structure (Kamada et al., 1992) , and some ATLL cells are multinucleated giant cells (Kikuchi et al., 1986; Taguchi et al., 1993) . Tax, a 40 kDa trans-activator encoded by HTLV-1, induces micro/multinuclei formation after nocodazole treatment. Jin et al. (1998) reported that Tax directly binds and interferes with human mitotic checkpoint protein Mad1, which may lead to CIN detected as multinuclei formation. Therefore, Tax induced CIN may be independent of its well-known trans-activator function. Other viral gene products such as human immunodeficiency virus Vpr, SV40 large T-antigen and Epstein-Barr virus LMP-1 also induce polyploidy and multinuclei formation in mammalian cells (Knecht et al., 1996; Chang et al., 1997; Shimura et al., 1999) .
Human Bub1/BubR1, which play an important role in the maintenance of accurate chromosomal segregation, bind to the kinetochore and delay mitotic phase in response to spindle disruption. Mutations and deletion of BUB1 and BUBR1 were detected in some aneuploid tumor cell lines and primary tumors (Cahill et al., 1998 (Cahill et al., , 1999 Ru et al., 2002; Hempen et al., 2003) . In addition, four of 10 ATLL cells with complex karyotypes had mutation/deletions in Bub1 or BubR1 (Ohshima et al., 2000) . These findings suggest that expression of Tax and inactivation of Bub1/BubR1 may cooperate to induce CIN phenotype, which enhances multistep carcinogenesis. Bub1v429, a mutant Bub1, has a missence mutation at codon 492 that results in substitution of tyrosine for a conserved serine. Previous report showed that Bub1v429 suppresses mitotic checkpoint function of Bub1 in the dominant-negative manner (Cahill et al., 1998) . Moreover, murine mutant Bub1 has been reported to suppress mitotic checkpoint and apoptosis in dominant-negative manner, and thus to form large and flat multinucleated cells (Taylor and Mckeon, 1997) . These results indicate that normal Bub1 has an important role as a component of mitotic checkpoint apparatus.
We questioned whether external expression of wildtype Bub1 would suppress the chromosomal missegregation and multinuclei formation like Mad1 (Jin et al., 1998) , and whether it is also effective to prevent the multinuclei formation induced by Tax. Our results showed that cells cotransfected with wild-type Bub1 and Tax suppressed multinuclei formation in nocodazole treated A549 cells. Further, in this paper, we present a detail phenotypic characterization and process of multinuclei formation in A549 cells transfected with wild/ mutant type BUB1 gene by using 48 h time-lapse videomicroscopy.
Results
Confocal laser microscopy confirms wild-type Bub1 localization at cytoplasm during interphase and at kinetochore during metaphase We investigated the expression level and intracellular distribution of internal Bub1 in A549, HeLa cells and normal bone marrow fibroblasts by confocal laser microscopy. As previously reported, endogenous Bub1 distributed in cytoplasm during interphase and concentrated at kinetochore during metaphase in these cells (Figure 1a, c, e) . Bub1 expression level calculated from confocal image microscopy of each cells was almost equal among A549, HeLa and normal fibroblasts.
External Bub1 distributes as native Bub1 in A549 and HeLa cells We constructed vector plasmids encoding wild-type and mutant Bub1 with EGFP at their N-terminal, and obtained several stable A549 and HeLa clones expressing one of these vectors or control one (EGFPC2). EGFP and Bub1 signals were colocalized in Bub1wt-EGFP-expressing clones (Figure 1b, d ). Bub1wt-EGFPexpressing A549 and HeLa cells showed apparently higher Bub1 signals than nontransfected ones, that is, 8.3-and 10.2-fold, respectively.
Constitutive expression of Bub1wt decreases multinuclei formation Inactivation of mitotic checkpoint proteins causes chromosomal mis-segregation, which leads to apoptosis, aneuploidy, or multinucleated cells. To investigate the possible role of Bub1 in the prevention of abnormal mitosis, we evaluated the morphology of A549 with or without external Bub1 expression. Giemsa staining revealed multinuclei formation in 69% of A549 cells expressing EGFP after 48 h of treatment with 200 ng/ml of nocodazole (Figure 2a ). Although prevalence of multinuclei formation was also more than 80% in Bub1v429-expressing cells, only 40% of Bub1wt-EGFP cells formed giant multinucleate cells (Figure 2b ). Our results suggested that external expression of normal Bub1 might suppress multinuclei formation. Furthermore, in these normal Bub1-expressing clones, adherent cell density was considerably reduced after Giemsa staining (Figure 2c ). To clarify the relation between the suppression of multinuclei formation and the decrease of cell density in normal Bub1 expressing clones, we observed each transfectant for 48 h with time-lapse microscopy.
Constitutional expression of Bub1wt prolong mitotic phase
We monitored cell behavior of each transfectant in the presence of nocodazole for 48 h. As shown in Figure 3A , A549 clones transfected with control EGFP or Bub1v429 vector displayed a rapid increase in mitotic population, peaking at 80% after 24 h. Over the next 24 h, the ratios of mitotic cells decreased to 15 and 28.8% in control EGFP-and mutant Bub1-expressing cells, respectively. Multinucleated cells appeared between 18 and 24 h after nocodazole treatment. During the following 24 h, prevalence of multinucleated cells was increased to 30.0 and 36.4% in control EGFP and Bub1v429 clones, respectively. Subsequently, apoptotic cells began to accumulate. In contrast, A549 Bub1wt population displayed a gradual increase in mitotic cells, peaking at 74.3% after 36 h nocodazole treatment, that is, the peak of mitotic cell percentage delayed about 12 h in Bub1wt clones compared with control or Bub1v429-expressing cells. Even after 48 h of nocodazole treatment, 58% of Bub1wt-expressing cells kept mitotic shape. Furthermore, in wild-type Bub1-expressing clones, percentage of multinucleated cells was only 4.1%, that is, about one-sixth of control-and mutant Bub1-expressing clones. 
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Time-lapse videomicroscopy showed that both mitotic and apoptotic cells were almost floating in the medium and their attachment to the bottom of the culture dish was very weak. During the methanol/ acetone fixation process, these cells seem to be detached from dish bottom. Furthermore, monitoring each cell behavior using time-lapse videomicroscopy showed an exceptional process of cell morphological change mainly in EGFP-and Bub1v429-expressing A549 cells. Most of these cells entered mitotic phase and showed rounded cellular shape in the presence of nocodazole. Some of them suddenly changed their morphology into unusual dynamic process 'mitotic lobulation' (Figure 4a ). After lobulation, these cells returned to sphere cellular shape and gradually stretched its cytoplasm. At this time, multinucleation became clear. The differences of mitotic lobulation from apoptosis were its time course and cell size (Figure 4b ). Lobulation pattern continued to change for 90-120 min and its cell size was over 20 mm. Apoptosis in A549 cells spent at least 200 min and cell size was smaller than 20 mm.
Taking the advantage of videomicroscopy, we next focused on each cell and analysed its fate. There existed three different cell fates after mitotic phase. First, the cells directly entered apoptosis; second, formed multinucleation; and third, entered apoptosis after multinucleation. As shown in Figure 3B , once normal Bub1-expressing cells entered mitosis, 67.7% retained at mitotic phase, 25.8% entered apoptosis, and only 6.5% of cells formed multinuclei at least during the 48 h of observation. In contrast, in control-and mutant Bub1-expressing clones, only 19.6 and 29.2% of cells retained at mitotic phase, 33.9 and 23.6% directly entered apoptosis, and 46.4 and 47.2% became multinucleated shape, respectively. Further examination showed that 30.8% (14.3/46.4) of control and 14.6% (6.9/47.2) of mutant Bub1-expressing multinucleated cells gradually entered apoptosis. These results indicated that the expression of normal Bub1 considerably decreased the prevalence of multinucleated cells.
The mean duration of mitotic phase was 18.5 and 20.0 h in control and Bub1v429 clones, respectively. In normal Bub1-expressing clones, the mitotic period prolonged over 25.0 h. There is statistical significance in mitotic duration of three transfectants (wt vs v429 or EGFP, P ¼ 0.000177, w 2 test and multiple comparison test). These results showed that external expression of normal Bub1 prevents the progression of mitotic process in the presence of abnormal chromosomal segregation.
Expression of Tax induces multinuclei formation HTLV-1-encoded Tax abrogates mitotic spindle checkpoint by binding Mad1 and induces multinuclei formation (Jin et al., 1998) . We transfected A549 cells with Tax expression vector, pH2R40M. Tax was reproducibly detected at least in 70% of A549 cells by confocal laser microscopy. As previously reported, Tax distributed at nuclear foci except nucleoli (Semmes and Jeang, 1996; Burton et al., 2000) . The results confirmed the proper expression of Tax in A549 cells ( Figure 5A ). Tax Figure 5B(a) ). Fixed cell densities after 24 h of nocodazole treatment between Tax-expressing and nonexpressing A549EGFP clones were almost equal ( Figure 5B(b) ). Therefore, the large difference of multinuclei percentage with or without Tax expression cannot be explained by the loss of mitotic and apoptotic population during the fixation process, and should warrant the enhancement of multinuclei formation by Tax.
Constitutive expression of Bub1wt deceases multinucleation induced by Tax
Tax is known to induce mitotic checkpoint aberrancy through the inhibition of Mad1. We examined whether overexpression of wild-type Bub1 suppresses the Taxinduced mitotic aberrancy. In EGFP-expressing A549 cells, Tax induced 39.8% of multinucleated cells after nocodazole treatment. In contrast, only 5.1% of normal Bub1-expressing A549 showed multinuclei formation after Tax transfection ( Figure 5C (a)). We also observed suppression of Tax-induced multinuclei formation by wild-type Bub1 in HeLa cells ( Figure 5C(b) ). To confirm the suppression of Tax-induced mitotic aberrancy by normal Bub1, we used videomicroscopy to monitor the behavior of Tax-transfected A549 clones with or without external expression of wild-type Bub1 in the presence of nocodazole. After 48 h, 16.9% of Taxtransfected A549EGFP cells became a multinucleated giant form. In contrast, Bub1wt/Tax transfectants showed dramatically low incidence of multinucleated cells (2.6%) (Figure 6 ). About 80% of Bub1wt/Tax cells retained at mitotic phase for more than 24 h. Therefore, overexpression of normal Bub1 should suppress the abnormal mitotic progression induced by Tax.
Discussion
Multinuclei formation is a phenotype of mitotic catastrophe induced by ionizing radiation or some of anticancer drugs, and can be easily distinguished from apoptotic cells by their morphology (Roninson et al., 2001) . A549 lung adenocarcinoma cell line forms multinuclei in the presence of nocodazole, and is aneuploid with 44-102 chromosomes (Isaka et al., 2003) . Therefore, this cell line should have a mitotic checkpoint abnormality. External expression of wild-type Bub1 significantly decreased the prevalence of multinuclei formation in A549, although control EGFP or mutant Bub1 lacked the ability to correct the aberrant mitotic process. This suppressive effect on mitotic aberrancy should not be a mere restoration of normal Bub1 function, because Bub1 mRNA has wild-type sequence (Yamaguchi et al., 1999) and endogenous Bub1 showed normal amount and distribution in A549. External expression of Bub1 should therefore suppress some defect(s) of other mitotic checkpoint Bub1 corrects mitotic aberrancy M Sasaki et al protein(s). To clarify this point, we examined the effect of wild-type Bub1 on Tax-induced mitotic aberrancy. Tax is known to disturb mitotic checkpoint by binding to and inactivating Mad1 (Jin et al., 1998) . External expression of wild-type Bub1 attenuated Tax-induced multinuclei formation in A549 cells. This phenomenon was also demonstrated in HeLa cell, although the prevalence of multinuclei was lower in this cell line (data not shown). These results argue that overexpression of wild-type Bub1 should correct mitotic checkpoint aberrancy induced by Mad1 inhibition. Bub1 could thus play its role downstream of Mad1 in the mitotic checkpoint pathway. However, this hypothesis is generally discordant with several previous reports (Jallepalli and Lengauer, 2001; Nigg, 2001; Yu, 2002) . We rather suppose that there might be functional redundancy between Bub1 and Mad1 in the mitotic checkpoint apparatus.
External expression of wild-type Bub1 remarkably decreased cell number after nocodazole treatment in Giemsa staining assay. Because mitotic and apoptotic cells were not well-fixed with methanol/acetone on the culture dish, considerable portion of wild-type Bub1-expressing cells should have stayed at the mitotic phase or underwent apoptosis after nocodazole treatment. Because mutant Bub1 was reported to suppress cells to enter apoptosis in the presence of mitotic stress (Taylor and Mckeon, 1997) , normal Bub1 might have an inverse effect, that is, might enforce aberrant mitotic cells into apoptosis. Monitoring each cell fate by time-lapse videomicroscopy clearly demonstrate wild-type Bub1 overexpression retained A549 cells at mitosis in the presence of nocodazole for at least 25 h during 48 h of observation. The observation demonstrated that normal Bub1 should simply enhance mitotic spindle checkpoint function even in the presence of other abnormalities in this checkpoint apparatus. Although about one-third of death-destined cells should form multinuclei morphology before really undergoing apoptosis in control EGFP-and mutant Bub1-expressing clones, no multinuclei formation was observed before apoptosis in wildtype Bub1-expressing clones. These results suggested that normal Bub1 should strictly suppress the aberrancy of mitotic spindle checkpoint.
Furthermore, videomicroscopy showed that nocodazole-treated cells underwent an unusual cellular morphological change; 'mitotic lobulation', before multinuclei formation. Almost all cells, which destined to form multinuclei, continued this dynamic change for 90-120 min. These cells once returned to sphere cellular shape, and then gradually stretched its cytoplasm and formed multinuclei morphology. This dynamic cellular change was different from apoptosis in cell size and its time course, and considered to be an unreported process of mitotic catastrophe.
Tax was known to inhibit Mad1 and induce mitotic aberrancy and chromosomal abnormalities (Jin et al., 1998) . Several ATLL cells have also genetic changes in BUB1/BUBR1 gene (Ohshima et al., 2000) . Therefore, Tax expression and Bub1/BubR1 inactivation may cooperate in the acquisition of CIN during the multistep carcinogenesis of ATLL. Simultaneous inactivation of both Bub1 and Mad1 pathways in clinical samples and our observation that wild-type Bub1 restore the mitotic checkpoint function even in the presence of Tax, suggest functional redundancy between Bub1 and other mitotic checkpoint protein(s) such as Mad1. From this point of view, transduction of wild-type Bub1 may provide a useful clinical tool to restore the normal mitotic checkpoint function in cells with CIN.
Materials and methods
Cell culture and generation of stable Bub1wt/Bub1v429-expressing cell lines A549, human lung cancer cell line, and their stable derivatives were maintained in Dulbecco's modified Eagle's medium (Sigma) with 10% fetal calf serum, 100 U/ml penicillin and 100 mg/ml streptomycin. Normal bone marrow fibroblasts were harvested from normal donors and cultured the same medium as cell lines. Wild-type and mutant Bub1 (Bub1wt and Bub1v429) cDNAs were subcloned as SacII and BamHI pEGFPC2 mammalian expression vector (Clontech) so that the EGFP fuses the N-terminal end of Bub1. A549 cells were transfected with 10 mg of each Bub1-expressing vector using calcium phosphate precipitation method (Chen and Okayama, 1987) and selected in G418. The transfected cells were further selected by fluorescence microscopy for expression of EGFP. To avoid clonal variation, at least three different clones of the transfectants were analysed. HeLa, human cervical cancer cell lines, transfectants were cloned and analysed in the same way.
Immunofluorescence and confocal laser microscopy Cells were fixed with 2% paraformaldehyde for 15 min at room temperature or methanol/acetone (7:3) for 15 min at À201C, dried and re-hydrated in PBS. EGFP signal was remained after 2% paraformaldehyde fixation, but completely vanished after methanol/acetone fixation. The following antibodies were used: anti-Bub1 goat polyclonal (Santa Cruz); LT-4 (antiTax) mouse monoclonal ; human autoimmune SLE sera (anti-nucleoli); Cy3-conjugated donkey anti-goat (Jackson Immuno Research Lab., Inc.); FITCconjugated goat anti-mouse (Sigma); TRITC-conjugated goat anti-human (Sigma). For indirect immunofluorescence, cells were incubated for 3 h with primary antibodies, washed three times with 0.1% Triton-100 in PBS, then incubated with FITC, TRITC or Cy3 conjugated secondary antibodies for 1 h, and then incubated cell with ToTo-3 Iodide (Molecular Probes) for 15 min. Images were recorded using LSM510 confocal laser microscope (Carl Zeiss) with PlanApo 100 Â /1.4 NA objective. Adobe Photoshop software was used to prepare Figures from the digitalized image obtained with the confocal microscope. The intensity of Bub1 signal was measured by Carl Zeiss LSM Image Browser Version 2.50 at least 30 cells per each for two clones, as previously reported (Tashiro et al., 1996) .
Multinuclei induction assay
Bub1-expressing clones were treated with 200 ng/ml nocodazole (Sigma) for 48 h. After nocodazole treatment, cells were fixed with methanol and stained with Giemsa's stain solution (Azur-eosin-methylene blue solution, Muto pure chemicals).
We evaluated the morphology of each cell under high-power microscopy at least 2000 cells per each transfectant and repeated at least three times for each clone. Multinucleated cells are defined as giant cells with nuclei more than three.
Time-lapse videomicroscopy, recording and documentation For time-lapse microscopy, cells were plated onto 35-mm glass bottom microwell dishes. Cells were monitored with 100 Â PlanApo objective mounted on TMD 300 microscope (Nikon). Cells were kept at 371C with a tissue culture warmer regulated by a temperature controller. Experiments were recorded using a video camera (Sony, DXC 9000) and a laser disk recorder (Sony, LVR-3000AN). Adobe Photoshop software was used to prepare Figures from the digitalized time-lapse image obtained with the laser disk recorder.
Additional transfection of tax A549 and HeLa cells transfected with 10 mg of pH2R40M, Tax-expressing vector , using phosphate precipitation the same method as above. After 24 h of transfection, cells were fixed methanol/acetone for confocal laser microscopy and treated with 200 ng/ml nocodazole for 48 h to observe by time-lapse videomicroscopy.
